In 2019, I joined the Innovation and Enterprise team at the Sanger to leverage my scientific expertise toward successful commercial development and dissemination of the cutting edge research taking place at the Institute as I believe this is the best way for these ideas to contribute to healthcare solutions.
I’m a post-doctoral level scientist with over 10 years of hands-on experience in various scientific disciplines including genetic regulation, stem cell biology, next-generation sequencing, and protein biochemistry.
Combined single-cell profiling of expression and DNA methylation reveals splicing regulation and heterogeneity.
Genome biology 2019;20;1;30
GATA6 Cooperates with EOMES/SMAD2/3 to Deploy the Gene Regulatory Network Governing Human Definitive Endoderm and Pancreas Formation.
Stem cell reports 2019;12;1;57-70
Laser Capture and Deep Sequencing Reveals the Transcriptomic Programmes Regulating the Onset of Pancreas and Liver Differentiation in Human Embryos.
Stem cell reports 2017;9;5;1387-1394
TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors.
Nature cell biology 2015;17;5;615-626
Exons 5-15 of kazrin are dispensable for murine epidermal morphogenesis and homeostasis.
The Journal of investigative dermatology 2012;132;8;1977-87
KazrinE is a desmosome-associated liprin that colocalises with acetylated microtubules.
Journal of cell science 2009;122;Pt 22;4035-41
The DH and PH domains of Trio coordinately engage Rho GTPases for their efficient activation.
Journal of molecular biology 2007;368;5;1307-20
Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
The Journal of pharmacology and experimental therapeutics 2004;311;3;1038-43